UB Paderborn / Katalog / Suche / in CDI

Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients

Clinical microbiology and infection, 2014-02, Vol.20 (2), p.160-166

2014

Link zum Volltext

Verfügbarkeit prüfen

Prise en charge de l’état réfractaire plaquettaire des hémopathies malignes. L’expérience IPC-EFSAM

Transfusion clinique et biologique (Paris), 2014-11, Vol.21 (4-5), p.207-209

2014

Link zum Volltext

Verfügbarkeit prüfen

Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2014-11, Vol.21 (4-5), p.207-209

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison

Leukemia, 2009-01, Vol.23 (1), p.194-196

2009

Link zum Volltext

Verfügbarkeit prüfen

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia : a donor vs no donor comparison

Leukemia, 2005-06, Vol.19 (6), p.916-920

2005

Link zum Volltext

Verfügbarkeit prüfen

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

Bone marrow transplantation (Basingstoke), 2000-08, Vol.26 (3), p.251-255

2000

Link zum Volltext

Verfügbarkeit prüfen

Allo-Immunisation anti-érythrocytaire et anti-HLA : conséquences

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2014-11, Vol.21 (4-5), p.245-246

2014

Link zum Volltext

Verfügbarkeit prüfen

Étude comparative des patients transfusés en concentrés plaquettaires (CP) a l’Institut Paoli-Calmettes (IPC)

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2017-09, Vol.24 (3), p.310-310

2017

Link zum Volltext

Verfügbarkeit prüfen

Évolution des protocoles transfusionnels en onco-hématologie 2011/2012

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2013-06, Vol.20 (3), p.338-338

2013

Link zum Volltext

Verfügbarkeit prüfen

Allo-immunisation érythrocytaire et transfusion plaquettaire

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2013-06, Vol.20 (3), p.311-311

2013

Link zum Volltext

Verfügbarkeit prüfen

Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level

Transfusion (Philadelphia, Pa.), 2004-04, Vol.44 (4), p.501-508

2004

Link zum Volltext

Verfügbarkeit prüfen

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-11, Vol.36 (10), p.901-906

2005

Link zum Volltext

Verfügbarkeit prüfen

Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation

Bone marrow transplantation (Basingstoke), 1997-06, Vol.19 (11), p.1155-1156

1997

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

Leukemia, 2003-04, Vol.17 (4), p.811-813

2003

Link zum Volltext

Verfügbarkeit prüfen

CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol

Bone marrow transplantation (Basingstoke), 1999-02, Vol.23 (4), p.387-394

1999

Link zum Volltext

Verfügbarkeit prüfen

Occult tumor cell contamination in patients with stage II III breast cancer receiving sequential high-dose chemotherapy

Bone marrow transplantation (Basingstoke), 2003-12, Vol.32 (11), p.1059-1064

2003

Link zum Volltext

Verfügbarkeit prüfen

Transfusions plaquettaires prophylactiques ou thérapeutiques dans le traitement des leucémies aiguës myéloblastiques : une comparaison rétrospective de deux centres

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2015-09, Vol.22 (4), p.203-203

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence of hepatitis C infection in 290 blood component recipients, demonstrated by several single-antigen research immunoassays

Transfusion (Philadelphia, Pa.), 1998-02, Vol.38 (2), p.194-198

1998

Link zum Volltext

Verfügbarkeit prüfen

Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate

Transfusion (Philadelphia, Pa.), 2005-05, Vol.45 (5), p.737-742

2005

Link zum Volltext

Verfügbarkeit prüfen

CD34+ immunoselected cells for poor graft function following allogeneic BMT

Cytotherapy (Oxford, England), 2000-01, Vol.2 (5), p.367-370

2000

Link zum Volltext

Verfügbarkeit prüfen

Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD

Bone marrow transplantation (Basingstoke), 1999-07, Vol.24 (2), p.225-227

1999

Link zum Volltext

Verfügbarkeit prüfen

Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma : an oligocentric report on 42 patients

Leukemia, 1999-06, Vol.13 (6), p.950-956

1999

Link zum Volltext

Verfügbarkeit prüfen

Older age does not influence allogeneic peripheral blood stem cell mobilisation in a population of mainly Caucasian donors.(Cellular and gene therapies)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S191

2009

Link zum Volltext

Verfügbarkeit prüfen

Autologous stem cell transplantation in elderly patients with multiple myeloma: age per se does not affect outcome.(Solid tumours/Multiple myeloma)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S19

2009

Link zum Volltext

Verfügbarkeit prüfen

Reduced-intensity conditioning umbilical cord blood transplantation in adults: age, disease status and infectious complications are important risk factors for outcome.(Reduced-intensity transplants)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S282

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients

Prise en charge de l’état réfractaire plaquettaire des hémopathies malignes. L’expérience IPC-EFSAM

Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia : a donor vs no donor comparison

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

Allo-Immunisation anti-érythrocytaire et anti-HLA : conséquences

Étude comparative des patients transfusés en concentrés plaquettaires (CP) a l’Institut Paoli-Calmettes (IPC)

Évolution des protocoles transfusionnels en onco-hématologie 2011/2012

Allo-immunisation érythrocytaire et transfusion plaquettaire

Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation

Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol

Occult tumor cell contamination in patients with stage II III breast cancer receiving sequential high-dose chemotherapy

Transfusions plaquettaires prophylactiques ou thérapeutiques dans le traitement des leucémies aiguës myéloblastiques : une comparaison rétrospective de deux centres

Lack of evidence of hepatitis C infection in 290 blood component recipients, demonstrated by several single-antigen research immunoassays

Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate

CD34+ immunoselected cells for poor graft function following allogeneic BMT

Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD

Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma : an oligocentric report on 42 patients

Older age does not influence allogeneic peripheral blood stem cell mobilisation in a population of mainly Caucasian donors.(Cellular and gene therapies)

Autologous stem cell transplantation in elderly patients with multiple myeloma: age per se does not affect outcome.(Solid tumours/Multiple myeloma)

Reduced-intensity conditioning umbilical cord blood transplantation in adults: age, disease status and infectious complications are important risk factors for outcome.(Reduced-intensity transplants)

Suchergebnisse filtern